452 related articles for article (PubMed ID: 16354858)
1. Maximal airway response to methacholine in cough-variant asthma: comparison with classic asthma and its relationship to peak expiratory flow variability.
Kang H; Koh YY; Yoo Y; Yu J; Kim DK; Kim CK
Chest; 2005 Dec; 128(6):3881-7. PubMed ID: 16354858
[TBL] [Abstract][Full Text] [Related]
2. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis.
Prieto L; Gutiérrez V; Bertó JM; Tornero C; Camps B; Pérez MJ
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):273-9. PubMed ID: 7552931
[TBL] [Abstract][Full Text] [Related]
3. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
[TBL] [Abstract][Full Text] [Related]
4. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine.
Yoo Y; Koh YY; Kang H; Yu J; Nah KM; Kim CK
Allergy; 2004 Oct; 59(10):1055-62. PubMed ID: 15355463
[TBL] [Abstract][Full Text] [Related]
5. Diurnal variation of peak expiratory flow in children with cough variant asthma.
Tokuyama K; Shigeta M; Maeda S; Takei K; Hoshino M; Morikawa A
J Asthma; 1998; 35(2):225-9. PubMed ID: 9576149
[TBL] [Abstract][Full Text] [Related]
6. Airway responsiveness to acetaldehyde in patients with asthma: relationship to methacholine responsiveness and peak expiratory flow variation.
Prieto L; Sánchez-Toril F; Brotons B; Soriano S; Casañ R; Belenguer JL
Clin Exp Allergy; 2000 Jan; 30(1):71-8. PubMed ID: 10606933
[TBL] [Abstract][Full Text] [Related]
7. Bronchial sensitivity and bronchial reactivity in children with cough variant asthma.
Mochizuki H; Arakawa H; Tokuyama K; Morikawa A
Chest; 2005 Oct; 128(4):2427-34. PubMed ID: 16236905
[TBL] [Abstract][Full Text] [Related]
8. Childhood cough variant asthma and its relationship to classic asthma.
Todokoro M; Mochizuki H; Tokuyama K; Morikawa A
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):652-9. PubMed ID: 12839325
[TBL] [Abstract][Full Text] [Related]
9. Methacholine and adenosine 5'-monophosphate challenges in preschool children with cough-variant and classic asthma.
Bakirtas A; Turktas I
Pediatr Pulmonol; 2007 Oct; 42(10):973-9. PubMed ID: 17722054
[TBL] [Abstract][Full Text] [Related]
10. Relationships of methacholine and AMP responsiveness with peak expiratory flow variability in children with asthma.
Yoo Y; Kim DK; Yu J; Choi SH; Kim CK; Koh YY
Clin Exp Allergy; 2007 Aug; 37(8):1158-64. PubMed ID: 17651145
[TBL] [Abstract][Full Text] [Related]
11. The importance of maximal airway response to methacholine in the prediction of wheezing development in patients with cough-variant asthma.
Koh YY; Park Y; Kim CK
Allergy; 2002 Dec; 57(12):1165-70. PubMed ID: 12464045
[TBL] [Abstract][Full Text] [Related]
12. Maximal airway response in adolescents with long-term asthma remission and persisting airway hypersensitivity: its profile and the effect of inhaled corticosteroids.
Koh YY; Park Y; Kim CK
Chest; 2002 Oct; 122(4):1214-21. PubMed ID: 12377844
[TBL] [Abstract][Full Text] [Related]
13. Methacholine vs adenosine on intra and extrathoracic airway hyperresponsiveness in patients with cough variant asthma.
Ribeiro M; Pereira CA; Nery LE; Beppu OS; Silva CO
Allergy; 2008 May; 63(5):527-32. PubMed ID: 18394126
[TBL] [Abstract][Full Text] [Related]
14. The relationship between delta-forced vital capacity (percent fall in forced vital capacity at the PC20 dose of methacholine) and the maximal airway response in patients who have mild asthma.
Yu J; Yoo Y; Kim DK; Koh YY
Allergy Asthma Proc; 2005; 26(5):366-72. PubMed ID: 16450571
[TBL] [Abstract][Full Text] [Related]
15. Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission.
Koh YY; Kang H; Yoo Y; Yu J; Nah KM; Kim CK
J Asthma; 2005 Feb; 42(1):17-23. PubMed ID: 15801323
[TBL] [Abstract][Full Text] [Related]
16. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
Prieto L; Gutiérrez V; Morales C
Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies.
Higgins BG; Britton JR; Chinn S; Cooper S; Burney PG; Tattersfield AE
Am Rev Respir Dis; 1992 Mar; 145(3):588-93. PubMed ID: 1546839
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Delta FVC (% decrease in FVC at the PC(20)) between cough-variant asthma and classic asthma.
Yoo Y; Yu J; Lee SH; Kim DK; Choi SH; Kim CK; Koh YY
J Asthma; 2007; 44(1):35-8. PubMed ID: 17365202
[TBL] [Abstract][Full Text] [Related]
19. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
[TBL] [Abstract][Full Text] [Related]
20. Small-airway obstruction, dynamic hyperinflation, and gas trapping despite normal airway sensitivity to methacholine in adults with chronic cough.
Sood N; Turcotte SE; Wasilewski NV; Fisher T; Wall T; Fisher JT; Lougheed MD
J Appl Physiol (1985); 2019 Feb; 126(2):294-304. PubMed ID: 30236044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
